Michael Miedema is a Cardiology physician affiliated with Abbott Northwestern Hospital. OpenAlex indexes 220 publications with 17,771 citations (h-index 42); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 E 28th St Ste H2100
Minneapolis, MN 554073723
Telephone
612-863-3900Provider last certified this registry record 10 Nov 2020.
Clinical trials
- The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial
Sponsor: Minneapolis Heart Institute Foundation
- diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED)
Sponsor: Minneapolis Heart Institute Foundation
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Canon Medical Informatics, Inc.Program year20252 payments
- Abbott LaboratoriesProgram year20251 payment
- HEARTFLOW, INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
89.8%Statin27.6%Rosuvastatin Calcium82%Atorvastatin Calcium17%Livalo1%Part D<11 patientsCholesterol absorption inhibitor15.3%Ezetimibe100%Part D≥167 patients+ 10 more classes in this area
Blood & clotting
7.7%Factor Xa inhibitor6.2%Eliquis77%Xarelto23%Part D≥45 patientsP2Y12 inhibitor1.5%Clopidogrel100%Part D≥19 patientsMetabolism & gastrointestinal
2.5%GLP-1 receptor agonist1.6%Ozempic63%Wegovy37%Part D<11 patientsPotassium supplement0.5%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Distribution of Coronary Artery Calcium by Age, Sex, and Race Among Patients 30-45 Years Old
Journal of the American College of Cardiology
2022 - Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing Among At-Risk Young Adults
Journal of the American College of Cardiology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Erik Schelbert, MD
Abbott Northwestern Hospital
Joao Cavalcante, MD
Abbott Northwestern Hospital
Vinayak Bapat, MD
Abbott Northwestern Hospital
Scott Sharkey, MD
Abbott Northwestern Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”